Table 1 Summary of AHA guidelines regarding the follow-up of patients with Kawasaki disease, starting at 1 year
From: Cardiovascular imaging in children and adults following Kawasaki disease
Risk level | Diagnostic testing | Interval | Invasive testing |
|---|---|---|---|
No CAA | Cardiovascular risk assessment | 5 years | None |
Transient CAAa | Cardiovascular risk assessment | 3–5 years | None |
Small-medium CAA (>3 mm but <6 mm, z-score 3–7) | Cardiovascular risk assessment Echocardiogram + ECG | 1 year 1 year | Invasive CAG if non-invasive test suggests ischemia |
Stress test with MPI | 2 years | ||
Large CAA (≥6 mm) or Multiple or complex CAA in 1 artery | Echocardiogram + ECG | one half year | Invasive CAG after 6–12 months and if any test or clinical finding suggests ischemia |
Stress test with MPI | 1 year | ||
Coronary artery obstruction | Echocardiogram + ECG | one half year | Invasive CAG for therapeutic options and if new onset or worsening myocardial ischemia is suggested |
Stress test with MPI | 1 year |